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Aquaporin 9 (AQP9) is a member of the aquaglyceroporin family that transports glycerol, urea and
other small solutes as well as water. Compared to the expression and function in epidermal kerat-
inocytes of AQP3, another aquaglyceroporin, our knowledge of epidermal AQP9 remains elusive. In
this study, we investigated the expression of AQP9 in the human epidermis and cultured keratino-
cytes. Immunoﬂuorescence studies revealed that AQP9 expression is highly restricted to the stratum
granulosum of the human epidermis, where occludin is also expressed at the tight junctions. Inter-
estingly, the AQP3 staining decreased sharply below the cell layers in which AQP9 is expressed. In
cultured normal human epidermal keratinocytes (NHEK), knock-down of AQP9 expression in the
differentiated cells induced by RNA interference reduced glycerol uptake, which was not as pro-
nounced as was the case with AQP3 knock-down cells. In contrast, similar reduction of urea uptake
was detected in AQP9 and AQP3 knock-down cells. These ﬁndings suggested that AQP9 expression in
NHEK facilitates at least the transport of glycerol and urea. Finally, we analyzed the effect of retinoic
acid (RA), a potent stimulator of keratinocyte proliferation, on AQP3 and AQP9 mRNA expression in
differentiated NHEK. Stimulation with RA at 1 lM for 24 h augmented AQP3 expression and down-
regulated AQP9 expression. Collectively, these results indicate that AQP9 expression in epidermal
keratinocytes is regulated in a different manner from that of AQP3.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The aquaporins (AQPs) are a family of small transmembrane
proteins that facilitate osmotically driven water transport. To date,
13 AQPs (AQP0-12) have been cloned from humans and are catego-
rized into distinct subgroups in terms of their amino acid sequence
and molecular functions: water-selective AQPs (AQPs 1, 2, 4, and
5), aquaglyceroporins that transport water and possibly other
small solutes such as glycerol and urea (AQPs 3, 7, 9 and 10), and
unorthodox AQPs (AQPs 6, 8, 11 and 12) [1–3].In the skin, AQP3 is highly expressed in the epidermis, espe-
cially in the basal layer and stratum spinosum [4,5]. AQP3 null
mice show impairments in hydration, elasticity, barrier recovery
and wound healing, indicating that AQP3 plays an important role
in skin physiology [6–8]. These defects are accompanied by dis-
turbed cell proliferation and migration in which AQP3-facilitated
water and glycerol transport are involved [9]. In cultured normal
human epidermal keratinocytes (NHEK), osmotic stress up-regu-
lates AQP3 gene expression, suggesting that AQP3 in keratinocytes
is involved in maintaining cellular osmolality [10]. In addition, sev-
eral biological factors have been shown to affect AQP3 expression
in keratinocytes. Retinoic acid (RA) increases AQP3 expression at
both mRNA and protein levels, indicating that RAR and RXR is
involved in the mediation of AQP3 gene expression [11–14]. Acti-
vation of peroxisome proliferators-activated receptor gamma
(PPARc) and liver X receptor (LXR) activators also induce AQP3
expression [14]. In contrast, tumor necrosis factor-a decreases
AQP3 expression in DJM-1 keratinocytes, and nicotinamide atten-
uates augmented AQP3 expression in HaCat cells treated with RA
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have been considered thorough the ﬁndings of the molecular func-
tions of AQP3 in keratinocytes and the factors that regulate its
expression.
Comparing with our knowledge of AQP3 in the epidermis and
keratinocytes, many features of AQP9, including its function and
expression, remain elusive. Through a series of phenotype analyses
of AQP9 knockout mice, AQP9 expression has been shown to be
highly restricted to the stratum granulosum (SG), but no apparent
defects were observed, including wound healing [17]. Our previous
studies showed that AQP9mRNA expression is only detected in dif-
ferentiated NHEK [10]. However, osmotic stress did not have any
effect on AQP9 expression under culture conditions. Similarly,
AQP9 expression in undifferentiated NHEK cultured in a low cal-
cium medium is not altered by treatment with PPAR, LXR, RAR or
RXR activators [14]. While both AQP9 and AQP3 are members of
the aquaglyceroporin family, these ﬁndings suggest that different
mechanisms underlie the regulation of AQP9 and AQP3 expression
in keratinocytes.
In this study, we examined AQP9 expression on human skin
sections to clarify its localization within the epidermis. Double
staining with occludin, a tight junction marker, was also performed
to distinguish the expression site of AQP9 from that of AQP3. In
order to ﬁnd out whether AQP9 in NHEK possesses the molecular
function of aquaglyceroporins, its permeability to glycerol and urea
was investigated. Finally, we demonstrated that RA decreases
AQP9 expression but increases AQP3 mRNA expression in differen-
tiated NHEK.
2. Materials and methods
2.1. Immunoﬂuorescence and immunohistochemical studies
Abdominal skin samples were obtained from healthy female
Caucasian donors (19 and 30 years of age) through Human and
Animal Bridging Research Organization (Tokyo, Japan) and BIOPRE-
DIC International (Rennes, France). The skin tissue samples were
embedded in Tissue-Tek O.C.T. compound (Sakura Finetek, Tor-
rance, CA), cut at 5 lmwith a cryostat, and ﬁxed with ice cold eth-
anol or acetone. The sections were rinsed with 0.05% Tween 20 in
phosphate-buffered saline (PBS-T). Nonspeciﬁc reactions were
blocked by incubating the sections in 1% bovine serum albumin
(BSA) in PBS (BSA/PBS) containing 10% normal goat serum for
30 min at room temperature. The sections were then incubated
with the following primary antibodies in BSA/PBS overnight at
4 C: rabbit anti- AQP3 antibody raised against a C-terminal pep-
tide (CHLEQPPPSNEEENVKLA), rabbit anti-AQP9 antibody (Alpha
Diagnostic Intl. Inc., Texas, USA). After washing in PBS-T, the sec-
tions were incubated with a Rhodamine Red-X conjugated goat
anti-rabbit IgG (Jackson Immuno Research. West Grove, PA,USA)
in BSA/ PBS for 1 h at room temperature, followed by rinsing in
PBS-T. For double immunoﬂuorescence studies, BSA/PBS-T con-
taining 10% normal goat and donkey serum, rat anti-mouse occlu-
din monoclonal antibody (MOC37, gifted from Dr. Mikio Furuse,
University of Kobe, Japan), and FITC conjugated donkey anti-rat
IgG (Jackson Immuno Research. West Grove, PA, USA) were used
as a blocking reagent, primary antibody and secondary antibody,
respectively. TO-PRO-3 iodide (Life Technologies Corporation, CA,
USA) was used for nuclear counter staining. The sections were
mounted using the SlowFade Antifade Kit (Molecular Probes, OR,
USA). Fluorescence signals were examined with a laser scanning
confocal microscope (Carl Zeiss LSM510, Jena, Germany). As con-
trol experiments for AQP9 staining, parafﬁn embedded skin sec-
tions were incubated with anti-AQP9 antibody preabsorbed with
either AQP9 blocking peptide (ADI_AQP91-P; Alpha Diagnostic Intl.
Inc., Texas, USA) or C-terminal peptide of AQP3 at 1 lg/ml. Biotinconjugated goat anti-rabbit IgG as a secondary antibody (Dako
Japan, Tokyo, Japan) and VECTASTAIN Elite ABC Kit (VECTOR LAB-
ORATORIES, INC., CA, USA) were used for detection. All protocols
were approved by the ethics committee of Kanebo Cosmetics Inc.
2.2. Cell culture and siRNA transfection
NHEK (Kurabo, Osaka, Japan) were cultured as described previ-
ously [18]. An siRNA solution was prepared using Lipofectamine
RNAiMAX Transfection Reagent according to the manufacturer’s
instructions (Life Technologies Corporation, CA, USA). After
20 min incubation at room temperature, 200 ll of 60 nM siRNA
solution was added to each well of a 12-well culture plate and then
NHEK (1.6  105 cells in 1 ml of MCDB 153 medium) were seeded
onto the well. After 2 days culturing under low Ca2+ condition
(0.1 mM Ca2+) when the cells were conﬂuent, the calcium concen-
tration was elevated to 1.25 mM to induce cell differentiation. siR-
NA for non-target control, AQP3 and AQP9 were purchased from
QIAGEN (Osaka, Japan). Aliquots of AQP3 and AQP9 siRNAmixtures
(AQP3: Hs_AQP3_2, Hs_AQP3_5, Hs_AQP3_6, Hs_AQP3_10; AQP9:
Hs_AQP9_1, Hs_AQP9_2, Hs_AQP9_4, Hs_AQP9_5) were used for
AQP3 and AQP9 knock-down, respectively. AllStars Negative Con-
trol siRNA was used as the non-target control.
2.3. Measurements of [14C]-glycerol and [14C] –urea transport
[14C]-glycerol (ARC0336) and [14C] –urea (ARC0150) were
obtained from American Radiolabeled Chemicals, Inc. (MO, USA).
NHEK culture and siRNA transfection were performed as described
above. After a 4-day culturing in the high calcium medium, the
cells were rinsed with PBS and incubated for 90 seconds in
500 lL of [14C]-glycerol or [14C]-urea solution (2 lCi/ml in
MCDB153 medium). The medium was removed and the cells
rinsed 5 times with ice-cold PBS containing 10 mM glycerol or
6.76 mM urea. After incubation in 400 ll of 0.5N NaOH and neu-
tralization with 100 ll of 2N HCl, the radioactivity of the cell
lysates was measured.
2.4. Analysis of AQP3 and AQP9 mRNA expression
Total RNA was prepared using an RNeasy Kit (Qiagen K. K.,
Tokyo, Japan). The cDNA was reverse transcribed from total RNA
samples using High Capacity cDNA Reverse Transcription Kits
according to the manufacturer’s protocol (Life Technologies
Corporation, CA, USA). Real-time PCR was performed using the
TaqMan technology on an Applied Biosystems StepOnePlus system
(Life Technologies Corporation, CA, USA). TaqMan probes,
Hs00185020_m1 and Hs01033360_m1 were used to analyze
AQP3 and AQP9 mRNA expression, respectively. The mRNA expres-
sion levels were normalized to that of 18S rRNA or glyceraldehyde
3-phosphate dehydrogenase (GAPDH). 1,25-dihydroxyvitamin D3
(VD3) and all-trans retinoic acid were purchased from Sigma-
Aldrich Japan (Tokyo, Japan)
2.5. Statistical analysis
Results are expressed as mean ± SD. The statistical signiﬁcance
of the difference between mean values was assessed by Dunnett’s
multiple comparison procedure and Student’s t-test.
3. Results
3.1. AQP9 was detected in the upper layer of the stratum granulosum
To examine the distribution of AQP9 in human skin, immuno-
ﬂuorescence studies on abdominal skin sections were performed.
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upper layer of the SG, not in the cells of the stratum spinosum or
basal layer. This staining pattern was consistent with that observed
on mouse epidermis [17]. The AQP9 antibodies preabsorbed with
antigen peptides did not show any speciﬁc staining. In contrast,
the staining for AQP9 was detected using AQP9 antibodies preab-
sorbed with antigen peptides for AQP3 antibodies (Fig. 1A, right
panels). To distinguish the localization of AQP9 from AQP3 in the
human epidermis, double staining was conducted with the tight
junctions (TJs) component occludin, as a marker. Occludin is highly
concentrated in TJs and its pattern of expression in the human epi-
dermis has been detected as small spots in the SG [19]. Meanwhile
the AQP3 staining decreased sharply below the cell layers where
occludin expression was positive, but AQP9 staining was highly
restricted to the occludin-positive cell layers (Fig. 1B). The signal
from AQP9 did not overlap with that from the occludin, suggesting
that AQP9 is not included in the TJs. These ﬁndings indicate that
AQP9 is highly localized in the upper layer of the SG and does
not co-exist with AQP3 in the human epidermis.
3.2. VD3 upregulated AQP9 mRNA expression in NHEK
As shown in Fig. 1, AQP9 was expressed in highly differentiated
cells in the human epidermis. In addition, our previous studyAQP3 AQ
A
B
Fig. 1. Immunoﬂuorescence staining for AQP9, AQP3 and occludin in the human epiderm
(19 years of age). AQP9 expression was detected in the upper layer of the SG (left panel)
experiments are shown in right panels. Immunohistochemical staining resulted in very si
antibody preabsorbed with antigen peptide (middle panel). The AQP9 staining was n
expression sites were analyzed using sequential skin sections (32 years of age). To dis
component occludin was used as the staining marker. AQP3 was highly expressed from t
the upper stratum granulosum. The nucleus was stained with TO-PRO-3 iodide. Arrowsshowed that AQP9 mRNA expression is only detected in differenti-
ating NHEK by an RNase protection assay [10]. VD3, a keratinocyte
differentiating agent [20,21], was added at 1 lM to NHEK at con-
ﬂuency and the cells were further cultured for 3 days. AQP9 mRNA
expression was signiﬁcantly induced by the VD3 treatment, while
the increase in expression was less pronounced compared to that
induced by elevated extracellular calcium (Fig. 2). This result sup-
ported the possibility that differentiation of keratinocytes triggers
AQP9 expression.
3.3. AQP9 siRNA transfection to NHEK reduced uptake of glycerol and
urea
To assess glycerol and urea permeability for AQP9 in NHEK,
[14C]-glycerol and [14C]-urea uptake were examined in siRNA
transfected cells. The uptake experiments were performed at
4 days after culturing in the high calcium medium, because AQP9
was highly expressed in differentiated keratinocytes. siRNA trans-
fection of AQP9 and AQP3 noticeably suppressed their mRNA
expression: AQP9 and AQP3 siRNA transfection noticeably sup-
pressed their mRNA expression; AQP9 and AQP3 mRNA expression
was 2.1% and 7.0% of non-target siRNA control, respectively
(Fig. 3A). In this culture condition, AQP9 knock-down cells showed
30.6% reduction of glycerol uptake compared with the cellsNo peptide
AQP9 peptide
AQP3 peptide
P9
is. (A) Immunoﬂuorescence studies were performed using abdominal skin sections
. The nucleus was stained with TO-PRO-3 iodide. Bar = 50 lm. The results of control
milar localization of AQP9 (top panel). The signal detected in SG was not observed by
ot affected in the presence of AQP3 peptide (bottom panel). (B) AQP3 and AQP9
tinguish the localization of AQP9 from AQP3 in the epidermis, the tight junction
he basal layer to the stratum spinosum. In contrast, AQP9 staining was restricted to
: occludin expression sites. Bar = 10 lm.
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Fig. 2. VD3 upregulated AQP9mRNA expression in NHEK. VD3 was added at 1 lM to
NHEK at conﬂuency in a low Ca2+ medium (0.15 mM) and the cells were further
cultured for 3 days. As a control inducing cell differentiation, Ca2+ concentration of
medium was elevated to 1.5 mM at the point of conﬂuency. AQP9 mRNA expression
was signiﬁcantly induced by VD3, a keratinocyte differentiation reagent. The mRNA
expression levels were normalized to that of GAPDH.
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48.0% (Fig. 3B). A further decrease in glycerol uptake was detected
for AQP3 and AQP9 double siRNA transfection. Urea uptake was
also signiﬁcantly reduced by both AQP9 and AQP3 siRNA transfec-
tion, but the rate of the reduction was small compared to the glyc-
erol uptake (Fig. 3C). This reduction was augmented by AQP3/AQP9
double siRNA transfection. Thus, AQP9 expression in keratinocytes
seemed to facilitate glycerol and urea transportation.
3.4. RA up-regulated AQP3 and down-regulated AQP9 mRNA
expression in differentiated NHEK
Recent reports demonstrated that RA, a potent stimulator of
keratinocyte proliferation, increases AQP3 expression in vitro and
in vivo. To investigate the effect of RA on AQP9 mRNA expression
in NHEK, differentiated cells were treated with RA at 1 lM for 80
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Fig. 3. AQP9 siRNA transfection to NHEK reduced [14C]-glycerol and [14C]-urea uptake. NH
plates. On day 4 after culturing in a high Ca2+ medium, glycerol and urea permeability w
AQP3 mRNA expression by siRNA transfection (A). AQP9 and AQP3 siRNA transfection red
Further decrease in uptake was detected with AQP3/AQP9 double siRNA transfection (B).
reduction was augmented by AQP3/AQP9 double siRNA transfection (C). The experimen
⁄p < 0.05, ⁄⁄p < 0.01).and 24 h (Fig. 4A, B). As previously reported, a remarkable augmen-
tation of AQP3 mRNA expression was detected at both 8 and 24 h
after the RA stimulation (2.3- and 2.0-fold, respectively). In con-
trast, AQP9 expression was not altered at 8 h and was signiﬁcantly
reduced at 24 h after the treatment (0.7-fold). The increase in AQP3
and decrease in AQP9 mRNA expressions was detected at lower
doses, 0.01 and 0.1 lM (Fig. 4C, D). These results were similar to
the cases in which hypertonic stress and PPAR gamma activation
were found to stimulate AQP3 mRNA expression in NHEK but have
little, if any, effect on AQP9 mRNA expression [10,14].
4. Discussion
AQP9 expression has been reported in many types of tissue
including the leukocytes, liver, brain and lung [2]. In human skin,
several studies have revealed abundant AQP3 expression from
the basal layer to the stratum spinosum of the epidermis, while
AQP9 distribution remains unclear. In our immunoﬂuorescence
studies, AQP9 expression was detected in the upper layers of the
human epidermis. A similar staining pattern has been reported in
a previous report in which AQP9 was detected speciﬁcally in the
single layer of the upper SG in a mouse epidermis [17]. In the
course of the wound healing process in mouse skin, AQP9 is also
observed in multiple layers in the SG. Our previous study demon-
strated that in cultured human keratinocytes, elevation of extracel-
lular calcium concentration to stimulate cell differentiation
triggers AQP9 mRNA expression [10]. In addition, further culturing
under high calcium conditions augmented AQP9 expression. The
treatment of cultured keratinocytes with VD3, a keratinocyte dif-
ferentiating agent, also signiﬁcantly increased AQP9 expression
(Fig. 2). These ﬁndings lead us to the possibility that AQP9 plays
a role in highly differentiated keratinocytes.
As in previous studies, immunoﬂuorescence testing in this
study also revealed high AQP3 expression from the basal layer to
the stratum spinosum in human skin. This AQP3 staining was not
detected in the cell layers where there was positive occludincontrol
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Fig. 4. RA upregulated AQP3 and downregulated AQP9 mRNA expression in NHEK. At conﬂuence, the cells were cultured for 4 days in a high Ca2+ medium to induce cell
differentiation. After that, the cells were treated with RA at 1 lM for 8 and 24 h. AQP3 mRNA expression was increased and AQP9 decreased by RA treatment (A, B). The
change in expression of AQP3 (after 8 h) and AQP9 (after 24 h) was detected at doses as low as 0.01 lM (C, D). The mRNA expression levels were normalized to that of 18S
rRNA. Values are means ± SD (n = 3; ⁄⁄p < 0.01).
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the occludin-positive cell layers of the SG. Neither AQP3 nor
AQP9 staining was observed in the portion beneath the occludin-
positive layers. With regards to the localization of AQP3 and
AQP9, the living cell layers of the epidermis could be divided into
AQP3-positive, AQP3/AQP9- negative and AQP9-positive. Allowing
that this interpretation is plausible, the biological and physiologi-
cal importance of AQP3 and AQP9 distribution in the epidermis
remain unclear.
Human and rat AQP9 have been independently identiﬁed from
leukocytes and liver. A series of study on Xenopus oocytes demon-
strated that human and rat AQP9 transport both water and non-
charged small solutes such as glycerol, urea, purines and pyrimi-
dines [22–24]. However, another study on Xenopus oocytes showed
human AQP9-induced permeability to be restricted to water and
urea [25]. As shown in Fig. 3B, AQP9 siRNA transfection into NHEK
remarkably reduced 14C-glycerol uptake under culture conditions,
which were not as pronounced as with AQP3 siRNA transfection.
Since differentiated NHEK in culture express both AQP3 and
AQP9, we examined glycerol uptake by conducting double trans-
fection of AQP3 and AQP9 siRNA. The double knock-down cells
revealed a further reduction in 14C-glycerol uptake, suggesting that
AQP9 in NHEK functions as an uptake mechanism for glycerol and
facilitates glycerol transport. In addition, although further studies
are required to investigate the conﬂicting results for glycerol per-
meability in human AQP9, our ﬁndings supported the fact that
human AQP9 exhibits glycerol permeability.
Recently, aquaglyceroporins have been shown in addition to
urea transporters as being involved in the urea transport mecha-
nism in NHEK [26]. In a series of inhibitor studies, treatment with
divalent cations inhibiting the water and solute permeability of
AQPs reduced 14C-urea uptake by NHEK. These experiments pre-
sented data that urea transport is inhibited by 34% by the ureatransporter inhibitor, thiourea, and by 66% by the AQP inhibitor,
mercury chloride. Our gene knock-down approaches also pre-
sented evidence that both AQP3 and AQP9 contribute to the uptake
of urea by NHEK (Fig. 3C). AQP3 or AQP9 siRNA transfection
revealed a reduction in 14C-urea uptake by NHEK of 11.7% and
9.4%, respectively. Further inhibition of urea uptake (24.4% reduc-
tion) was achieved by double transfection with AQP3 and AQP9
siRNA. Thus, both AQP3 and AQP9 expressed in NHEK are thought
to be involved in urea transport mechanisms. Grether-Beck et al.
reported that urea is a small-molecule regulator of epidermal per-
meability barrier function and antimicrobial peptide expression.
While further studies are needed to clarify the physiological signif-
icance of urea transport through urea transporters and/or AQPs, it
is considered that AQP9 localized in the upper SG may play an
important role in the barrier function.
In a separate experiment, we examined the osmotic water per-
meability of AQP9 expressed in NHEK using a SX20 stopped-slow
spectrometer. Unlike glycerol and urea permeability, AQP9 siRNA
transfection did not affect water transportation under culture con-
ditions (data not shown). Proteoliposome reconstructed with puri-
ﬁed rat AQP9 protein exhibited high glycerol and urea permeability
in a mercurial-sensitive manner, but only minimal osmotic water
permeability [27]. Water permeability of erythrocytes from
AQP9-null mice remained intact, whereas glycerol transport was
substantially decreased [28]. AQP9 expressed in keratinocytes
may play only a small role as a water channel.
RA is well known to be a critical regulator of proliferation and
differentiation of keratinocytes [29,30]. RA stimulates proliferation
of basal keratinocytes, leading to an accelerated turnover and
thickening of the epidermis [31–33]. Several studies have shown
that RA is a potent inducer of AQP3 expression in keratinocytes.
Topical application of RA on mouse and human skin explants
exhibited a marked increase in AQP3 expression in the epidermis
616 Y. Sugiyama et al. / FEBS Open Bio 4 (2014) 611–616[11,13]. Notably, in these studies intense AQP3 staining was
observed in both basal and suprabasal keratinocytes. The up-regu-
lation of AQP3 expression by RA has been also demonstrated in
undifferentiated and differentiated keratinocytes in culture [14].
In our study, RA was added to keratinocytes 4 days after calcium-
induced differentiation. This RA treatment signiﬁcantly increased
AQP3 mRNA expression as shown in Fig. 4A. Thus AQP3 in kerati-
nocytes appears to be up-regulated by RA, independent of cell
differentiation.
In contrast, AQP9 mRNA expression in differentiated NHEK was
reduced by 24 h of RA treatment (Fig. 4B). The down-regulation of
AQP9 and corresponding up-regulation of AQP3 mRNA expression
in the differentiated cells was detected at doses as low as 0.01 lM
(Fig. 4C, D). RA regulates many markers of epidermal differentia-
tion. It suppresses the expression of differentiation-associated
components such as keratin 1, keratin 10, loricrin, proﬁlaggrin/ﬁl-
aggrin and transglutaminase I in cultured keratinocytes [29]. A
similar phenomenon has been reported in NHEK transfected by
dual oxidase I (DUOX1) siRNA, in which AQP9 mRNA expression
as well as the differentiation markers mentioned above are inhib-
ited [34]. DUOX1 is thought to be a major enzyme that produces
H2O2 and contributes to keratinocyte differentiation in response
to Ca2+. Taken together with the AQP9 expression in the upper
SG of the human epidermis (Fig. 1) and the up-regulation by VD3
in culture (Fig. 2), AQP9 is thought to be one of the group of differ-
entiation markers that plays a role in terminal differentiation of
the epidermis.
In summary, AQP9 expression was highly restricted to the
upper stratum granulosum of the human epidermis where AQP3
expression was diminished. RA treatment of differentiated NHEK
in culture up-regulated AQP3 and down-regulated AQP9 mRNA
expression. These ﬁndings suggest that the regulation of AQP9
expression is totally different from that of AQP3. Occludin, a tight
junction marker, was detected in the epidermal layers expressing
AQP9, indicating that AQP9 co-exists in the upper SG where the
tight junctions are formed. Considering that the tight junctions
function as a paracellular barrier against small molecules, the pres-
ence of AQP9 in the human epidermis may have a role to play as a
conduit for inside-to-outside and/or outside-to-inside movement
of glycerol and urea.
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